European Pharmacopoeia / General | News | 20 May 2020 | Strasbourg, France
The EDQM is organising four free webinar training sessions on the European Pharmacopoeia and related activities of the EDQM. These webinars will cover many important aspects of the work and procedures of the European Pharmacopoeia (e.g. impurity controls or new and revised chapters), the establishment and use of Ph. Eur. Reference Standards, as well as an overview of the Certification of...
European Pharmacopoeia / General | News | 18 May 2020 | Strasbourg, France
The European Pharmacopoeia Commission granted observer status to Mexico during its 166th session (March 2020). This decision demonstrates the dynamism of the European Pharmacopoeia (Ph. Eur.), which now has 30 observers from around the world in addition to the 39 European countries and the European Union as signatory parties.
European Pharmacopoeia / Medicine for veterinary use | News | 14 May 2020 | Strasbourg, France
The new edition of the Technical Guide for the elaboration and use of monographs for immunological veterinary medicinal products (2020) was approved by the European Pharmacopoeia (Ph. Eur.) Commission at its 166th session.
Products and Services | News | 12 May 2020 | Strasbourg, France
The 2021 subscriptions to the European Pharmacopoeia Supplements 10.3-10.5 are now available on the EDQM WebStore. Two subscription formats are available: 1. Electronic version (access until 31 December 2021 - bilingual English and French); 2. Print version (available in English or French)
European Pharmacopoeia / Ph. Eur. Commission | News | 11 May 2020 | Strasbourg, France
At its 166th session (March 2020), the European Pharmacopoeia (Ph. Eur.) Commission adopted a new chapter on Multivariate Statistical Process Control (5.28). The Ph. Eur. is the first pharmacopoeia to tackle this topic.
European Pharmacopoeia / Ph. Eur. Commission | News | 06 May 2020 | Strasbourg, France
At this session, the Ph. Eur. Commission adopted 91 texts for publication in Ph. Eur. Supplement 10.4, including 11 new texts. The list of all adopted texts will be made available on the EDQM website: Ph. Eur. Work Programme and Ph. Eur. publication schedule. These texts will be effective as of 1 April 2021 and will be published in Supplement 10.4 of the Ph. Eur.
EDQM / All activities | News | 06 May 2020 | Strasbourg, France
The EDQM’s core activities include the provision of documentary and physical (reference) standards to ensure the quality of medicines and their ingredients. Availability of and access for patients to quality medicines is more important than ever in the context of the current COVID-19 pandemic.
European Pharmacopoeia / International harmonisation | News | 28 April 2020 | Strasbourg, France
The Pharmacopoeial Discussion Group (PDG) held its interim videoconference on Thursday 12 March 2020. The PDG – which brings together the European Pharmacopoeia (Ph. Eur.), the Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP), with WHO (International Pharmacopoeia) as Observer, to discuss international harmonisation of quality standards – has now completed work on 28 of the 31...
EDQM / All activities | News | 24 April 2020 | Strasbourg, France
Free training resources: online sessions for home learning – Sign up today! Online training is the ideal way to improve your skills during quarantine. Why not make the most of your time at home to pick up new skills and gain valuable knowledge by attending an online training session? The good news is that all the EDQM training sessions and webinars are available free online, covering a wide...
European Pharmacopoeia / General | News | 20 April 2020 | Strasbourg, France
The European Pharmacopoeia and the British Pharmacopoeia have worked together to make supportive pharmacopoeial texts (monographs, general chapters, appendices and supplementary chapters) available for a limited period of time at no cost to users. This is to support those developing, manufacturing or testing these substances and products during this challenging period. These texts will be...
European Pharmacopoeia / Monograph | News | 17 April 2020 | Strasbourg, France
The EDQM would like to inform users of the European Pharmacopoeia of the forthcoming correction of the limit for sulfated ash in the French version of the Kanamycin monosulfate (0032) monograph. The limit which is given as 1.5% in the French version will be corrected to 0.5% as it appears in the English version of the text.
Paediatric Formulary | News | 17 April 2020 | Strasbourg, France
The European Paediatric Formulary (PaedF) Working Party, in this exceptional situation, wishes to serve pharmacists by compiling existing knowledge on paediatric formulations for active substances under investigation as well as known authorised medicinal products. Information on paediatric formulations of active substances used in clinical trials but also experimentally in clinical practice...
European Pharmacopoeia / Public enquiry | News | 16 April 2020 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) currently includes two monographs on oxygen: Oxygen (0417) and Oxygen (93 per cent) (2455).
European Pharmacopoeia / Public enquiry | News | 15 April 2020 | Strasbourg, France
All new texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. The deadline for comments on Pharmeuropa 32.2 is 30 June 2020.
European Pharmacopoeia | News | 07 April 2020 | Strasbourg, France
The European Pharmacopoeia (Ph. Eur.) is seeking feedback on its new general chapter on the analysis of N-nitrosamine impurities in active substances (2.4.36).